↓ Skip to main content

Risk of Cardiovascular Disorders in Psoriasis Patients

Overview of attention for article published in American Journal of Clinical Dermatology, December 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
118 Mendeley
Title
Risk of Cardiovascular Disorders in Psoriasis Patients
Published in
American Journal of Clinical Dermatology, December 2012
DOI 10.1007/s40257-012-0005-5
Pubmed ID
Authors

Ingrid L. D. Tablazon, Amir Al-Dabagh, Scott A. Davis, Steven R. Feldman

Abstract

Psoriasis is an inflammatory autoimmune disease that affects the skin. Recently, psoriasis and its consequential lifestyle and dietary habits have been associated with increased risks for cardiovascular diseases. This article discusses the connection between cardiovascular disorders and psoriasis and the effects of available treatment options on cardiovascular risk. A PubMed search revealed 11 articles that were analyzed for information regarding this association, its effects, and potential courses of treatment. Both the presence and severity of psoriasis increases the risk for cardiovascular disorders and co-morbidities. Forty percent of psoriasis patients met metabolic syndrome criteria as compared with 23 % of non-psoriasis control subjects. Rate ratios for atrial fibrillation are correlated with the severity of psoriasis; patients with severe and mild psoriasis produced rate ratios of 1.63 and 1.31, respectively. Studies also show an increase in the risks for myocardial infarction, atherosclerosis, ischemic stroke, and other cardiovascular disorders. The exact mechanisms behind this affiliation are still uncertain; however, the psychological and physiological effects of psoriasis and the overlapping pathogenesis behind atherosclerosis and psoriasis may play a role. Since the risk for cardiovascular disorders increases with the presence and severity of psoriasis, psoriasis treatment should not only address the disease and its symptoms, but also its co-morbidities. Recent National Psoriasis Foundation (NPF) guidelines have provided recommendations for psoriasis patient care. Histories of co-morbidities, screenings for potential diseases, increased exercise, decreased alcohol consumption, and smoking cessation should be implemented. Unfortunately, while there are data for the increased risk for cardiovascular diseases within psoriasis patients, there are presently no data stating that increasing cardiovascular screening rates in patients produces a significant difference.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ireland 1 <1%
Unknown 117 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 17%
Student > Master 19 16%
Student > Ph. D. Student 15 13%
Researcher 13 11%
Other 9 8%
Other 15 13%
Unknown 27 23%
Readers by discipline Count As %
Medicine and Dentistry 52 44%
Pharmacology, Toxicology and Pharmaceutical Science 9 8%
Nursing and Health Professions 7 6%
Agricultural and Biological Sciences 4 3%
Biochemistry, Genetics and Molecular Biology 4 3%
Other 12 10%
Unknown 30 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2018.
All research outputs
#1,853,459
of 22,691,736 outputs
Outputs from American Journal of Clinical Dermatology
#121
of 973 outputs
Outputs of similar age
#18,015
of 277,760 outputs
Outputs of similar age from American Journal of Clinical Dermatology
#2
of 9 outputs
Altmetric has tracked 22,691,736 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 973 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,760 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.